WengerTMillerDEvansK. FGFR Craniosynostosis syndromes overview. In: AdamMPArdingerHHPagonRA, et al, eds. GeneReviews®. University of Washington, Seattle; 1993-2020.
2.
NagaseTNagaseMHiroseSOhmoriK.Crouzon syndrome with acanthosis nigricans: case report and mutational analysis. Cleft Palate Craniofacial J. 2000;37:78-82. doi:10.1597/1545-1569_2000_037_0078_cswanc_2.3.co_2
3.
GalvinBDHartKCMeyerANWebsterMKDonoghueDJ.Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras. Proc Natl Acad Sci U S A. 1996;93:7894-7899. doi:10.1073/pnas.93.15.7894
4.
LuxSETseWTMenningerJC, et al. Hereditary spherocytosis associated with deletion of human erythrocyte ankyrin gene on chromosome 8. Nature. 1990;345:736-739. doi:10.1038/345736a0
5.
EberSWGonzalezJMLuxML, et al. Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. Nat Genet. 1996;13:214-218. doi:10.1038/ng0696-214
6.
Bolton-MaggsPHBLangerJCIolasconATittensorPKingMJ. Guidelines for the diagnosis and management of hereditary spherocytosis—2011 update. Br J Haematol. 2012;156:37-49 doi:10.1111/j.1365-2141.2011.08921.x
7.
Passos-BuenoMRSertiéALRichieri-CostaA, et al. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses. Am J Med Genet. 1998;78:237-241. doi:10.1002/(sici)1096-8628(19980707)78:3<237::Aid-ajmg5>3.0.Co;2-m
de RavelTJLTaylorIBVan OostveldtAJTFrynsJPWilkieAOM.A further mutation of the FGFR2 tyrosine kinase domain in mild Crouzon syndrome. Eur J Hum Genet. 2005;13:503-505. doi:10.1038/sj.ejhg.5201325
13.
GorielyALordHLimJ, et al. Germline and somatic mosaicism for FGFR2 mutation in the mother of a child with Crouzon syndrome: implications for genetic testing in “paternal age-effect” syndromes. Am J Med Genet A. 2010;152a:2067-2073. doi:10.1002/ajmg.a.33513
